Skip to content

Pasi Antero Janne

Dana-Farber Cancer Institute

3 papers in the Anchorcite directory, published between 2004 and 2010, cited 18,491 times in total.

ORCID profile

Research topics

Frequent co-authors

  • Neal Ian Lindeman · 2 papers
  • Bruce Evan Johnson · 2 papers
  • Jeffrey A. Engelman · 2 papers
  • James G. Christensen · 2 papers
  • J. Guillermo Paez · 1 paper
  • Jeffrey C. Lee · 1 paper
  • Sean I. Tracy · 1 paper
  • Heidi E. Greulich · 1 paper

Papers

  1. EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience · 2004 · 9,452 citations

    Receptor tyrosine kinase genes were sequenced in non-small cell lung cancer (NSCLC) and matched normal tissue. Somatic mutations of the epidermal growth factor receptor gene EGFR were found in 15of 58 unselected tumors from Japan and 1 of 61 from…

  2. MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 SignalingScience · 2007 · 4,559 citations

    The epidermal growth factor receptor (EGFR) kinase inhibitors gefitinib and erlotinib are effective treatments for lung cancers with EGFR activating mutations, but these tumors invariably develop drug resistance. Here, we describe a gefitinib-sensitive lung cancer cell line that developed resistance…

  3. Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung CancerNew England Journal of Medicine · 2010 · 4,480 citations

    BACKGROUND: Oncogenic fusion genes consisting of EML4 and anaplastic lymphoma kinase (ALK) are present in a subgroup of non-small-cell lung cancers, representing 2 to 7% of such tumors. We explored the therapeutic efficacy of inhibiting ALK in such tumors in…

Metadata from OpenAlex (CC0).